These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7596256)

  • 21. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
    Zielińska W; Korczak-Rogoń A; Paszkiewicz J; Kowalik M; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):359-66. PubMed ID: 9017152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatitis C--clinical aspects, diagnosis and therapy].
    Mörl M
    Fortschr Med; 1997 Jan; 115(3):26-9. PubMed ID: 9102384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autoimmune thrombocytopenic purpura after treatment of chronic viral hepatitis C with interferon].
    Maïga MY; Oberti F; Foussard C; Calès P
    Gastroenterol Clin Biol; 1995; 19(8-9):739-40. PubMed ID: 8522132
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of chronic hepatitis C with recombinant interferon alfa.
    Chen YK; Bala K
    West J Med; 1992 Jan; 156(1):72. PubMed ID: 1734608
    [No Abstract]   [Full Text] [Related]  

  • 27. [What are the indications for interferon therapy with regard to the significance of serologic and histologic findings and laboratory data?].
    Gerken G
    Internist (Berl); 1993 Nov; 34(11):1062-5. PubMed ID: 8282492
    [No Abstract]   [Full Text] [Related]  

  • 28. [Attempted suicide during treatment of chronic viral hepatitis C with interferon. Apropos of 2 cases].
    Bourat L; Larrey D; Michel H
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1063. PubMed ID: 8729421
    [No Abstract]   [Full Text] [Related]  

  • 29. [Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C].
    Moulin V; Harzic M; Doll J; Dubeaux B; Ghnassia JC; Andrieu J
    Pathol Biol (Paris); 1996 May; 44(5):468-72. PubMed ID: 8758497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The successful treatment of chronic active hepatitis due to hepatitis C viral infection with alpha-interferon and a cytokine complex (a clinical case)].
    Karpov VV; Krel' PE
    Ter Arkh; 1995; 67(5):84-5. PubMed ID: 7638792
    [No Abstract]   [Full Text] [Related]  

  • 31. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Porphyria cutanea tarda and chronic hepatitis C. Course after interferon therapy].
    Grasset D; Nougué J; Seigneuric C; Landreaud M; Voigt JJ
    Gastroenterol Clin Biol; 1994; 18(12):1148-9. PubMed ID: 7750693
    [No Abstract]   [Full Text] [Related]  

  • 33. [Esophageal candidiasis during interferon therapy for chronic viral hepatitis C].
    Prignet JM; Galzin M; Demarquay JF; Raynard B; Louvety S; Künkel D
    Gastroenterol Clin Biol; 1994; 18(8-9):796-7. PubMed ID: 7875459
    [No Abstract]   [Full Text] [Related]  

  • 34. [Interferon-alpha in the treatment of chronic viral hepatitis].
    Melman ML
    Rev Gastroenterol Mex; 1994; 59(2 Suppl):46-8. PubMed ID: 8091094
    [No Abstract]   [Full Text] [Related]  

  • 35. [The immune status of patients with chronic viral hepatitis type C and the clinico-therapeutic implications].
    Jirillo E; Caradonna L; Greco B; Satalino R; Pugliese V; Cozzolongo R; Rosina F; Cuppone R; Manghisi PG
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):29-32. PubMed ID: 7619960
    [No Abstract]   [Full Text] [Related]  

  • 36. [Interferon therapy in hepatitis C].
    Ferenci P
    Wien Med Wochenschr; 1993; 143(16-17):461-4. PubMed ID: 8273373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alpha-interferon in the treatment of chronic hepatitis C in children].
    Cinquetti M; Marchi D
    Pediatr Med Chir; 1995; 17(6):501-7. PubMed ID: 8668583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis C, diagnosis and therapy].
    Moradpour D; Blum HE
    Med Klin (Munich); 1996 Dec; 91(12):769-70. PubMed ID: 9082162
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cryoglobulinemia in chronic hepatitis C. Improvement by alpha-interferon is independent of virus elimination].
    Glück T; Dürk H; Kötter I; Zimmermann C; Saal JG
    Med Klin (Munich); 1995 Dec; 90(12):674-80. PubMed ID: 8583982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
    Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P
    Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.